12900 Results (Page 506 of 516)
All Market Research Reports
Spain Kidney Cancer Therapeutics Market Analysis
The Spain Kidney Cancer Therapeutics Market was valued at $121.40 Mn in 2023 and is predicted to grow at a CAGR of 3.86% from 2023 to 2030, to $158.25 Mn by 2030. The key drivers of this industry include the increasing prevalence of kidney cancer due to lifestyle and environmental factors, early detection, and advancement in diagnostic tools. The key players in the industry are Pfizer, Novartis, Grupo Ferrer, Laboratorios Farmacéuticos Rovi, Roche, Bristol Myers Squibb, and AstraZeneca among others.
Kenya Clinical Nutrition Market Analysis
The Kenya Clinical Nutrition Market was valued at $21.5 Mn in 2023 and is projected to grow at a CAGR of 6.44% from 2023 to 2023, to $33.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Nutrivea, Healthwise Kenya, Haltons Pharmacy, Mead Johnson & Company, GSK, Unilever among others.
Brazil Digital Biomarkers Market Analysis
Brazil Digital Biomarkers Market was valued at $72.50 Mn in 2023 and is predicted to grow at a CAGR of 23.3% from 2023 to 2030, to $314.11 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and rising healthcare costs. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Kenya Breast Pump Market Report
The Kenya Breast Pump Market was valued at $2.1 Mn in 2023 and is predicted to grow at a CAGR of 9.7% from 2023 to 2030, to $3.9 Mn by 2030. The key drivers of the market include the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the Kenya Breast Pump Market are Amaze Surgicare, Chemco, Medela, Ameda, Avent, Evenflo, Pigeon, Playtex, Perifit, and Philips Avent, among others.
Mexico Cancer Induced Bone Disease Therapeutics Market
Mexico Cancer Induced Bone Disease Therapeutics Market valued at $20 Mn in 2022, projected to reach $31 Mn by 2030 with a 6.05% CAGR. The key drivers of this industry include the increasing incidence of cancer, improved diagnostics and treatment, and expanding treatment options. The industry is primarily dominated by players such as Amgen, Novartis, Pfizer, Roche, Eli Lilly, Genomma, and Bayer among others.
South Africa Clinical Nutrition Market Analysis
The South Africa Clinical Nutrition Market was valued at $199.4 Mn in 2023 and is projected to grow at a CAGR of 6.57% from 2023 to 2023, to $311.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Herbalife Nutrition, Optimum Nutrition, Abbott Nutrition, Pfizer Inc, Nestle, Mead Johnson & Company, LLC among others.
Mexico Digital Biomarkers Market Analysis
Mexico Digital Biomarkers Market was valued at $43.50 Mn in 2023 and is predicted to grow at a CAGR of 22.55% from 2023 to 2030, to $180.59 Mn by 2030. The key drivers of this industry include rising chronic disease burden, increased smartphone penetration, growing focus on preventative care, and government initiatives. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
South Africa Breast Pump Market Report
The South Africa Breast Pump Market was valued at $19.1 Mn in 2023 and is predicted to grow at a CAGR of 9.83% from 2023 to 2030, to $36.8 Mn by 2030. The key drivers of the market include the rising female workforce, technological features, and growing awareness. The prominent players in the South Africa Breast Pump Market are Bistos, Ameda, Avent, Evenflo, and Pigeon, among others.
Japan Cancer Induced Bone Diseases Therapeutics Market
Japan Cancer Induced Bone Disease Therapeutics Market valued at $81 Mn in 2022, projected to reach $132 Mn by 2030 with a 6.3% CAGR. The key drivers of this industry include the increasing cancer incidence, technological advancements, and unmet medical needs. The industry is primarily dominated by players such as Daiichi Sankyo, Bayer, Merck, Chugai, Takeda, Novartis, Amgen, and Eisai among others.
Brazil Congestive Heart Failure Therapeutics Market Analysis
The Brazil Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $258 Mn in 2022 to $436 Mn by 2030, with a CAGR of 6.8% during the forecast period of 2022-2030. An expanding patient base due to rising cardiac disease prevalence, increased healthcare access around the country, and a thriving R&D environment are the key factors driving the market growth in Brazil. The Brazil Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including Johnson & Johnson, Merck, Novartis, Pfizer, Sanofi, Hypera Pharma, Ache Laboratories, EMS Pharma, Neo Quimica, Teuto Brasileiro, etc, among various others.
India Clinical Nutrition Market Analysis
The India Clinical Nutrition Market was valued at $557.8 Mn in 2023 and is projected to grow at a CAGR of 8.34% from 2023 to 2023, to $977.2 Mn by 2030. The key drivers of this industry are increasing prevalence of chronic diseases and metabolic disorders, aging population, increasing awareness of the importance of nutrition for health, product innovations and technological advancements, government initiatives and rising healthcare expenditure, rising incidence of malnutrition especially in paediatric patients which has contributed to market growth. The industry is primarily dominated by players such as Sun Pharmaceuticals, Zydus Wellness, Glenmark Pharmaceuticals, Zeon Lifesciences, Nestle, Mead Johnson & Company, LLC among others.
Spain Digital Biomarkers Market Analysis
Spain Digital Biomarkers Market was valued at $55.97 Mn in 2023 and is predicted to grow at a CAGR of 21.3% from 2023 to 2030, to $216.26 Mn by 2030. The key drivers of this industry include the high burden of chronic diseases, the advanced healthcare system, and the growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
India Breast Pump Market Report
The India Breast Pump Market was valued at $53.5 Mn in 2023 and is predicted to grow at a CAGR of 11.6% from 2023 to 2030, to $115.3 Mn by 2030. The key drivers of the market include the improving healthcare infrastructure, growing consumer awareness, and rising disposable incomes. The prominent players of the India Breast Pump Market are Advin Healthcare, Chemco, NaugraMedical, Medicon Healthcare, Akshar Pharma, and Amkay, among others.
Brazil Cancer Induced Bone Disease Therapeutics Market
Brazil Cancer Induced Bone Disease Therapeutics Market valued at $33 Mn in 2022, projected to reach $55 Mn by 2030 with a 6.8% CAGR. The key drivers of this industry include the rising incidence of cancer, improved diagnostics and treatment, and the potential for local manufacturing. The industry is primarily dominated by players such as Advaxis, CancerVax, Pfizer, Takeda, Gradalis, Hikma, and Zentalis among others.
Canada Congestive Heart Failure Therapeutics Market Analysis
The Canada Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $0.824 Bn in 2022 to $1.294 Bn by 2030, with a CAGR of 5.8% during the forecast period of 2022-2030. The key drivers of the Canadian congestive Heart Failure Therapeutics Market include the increasing prevalence of risk factors leading to CVS disorders, advancements in medical technology and intervention options, and supportive government schemes and reimbursement strategies. The Canada Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AbbVie, Amgen, AstraZeneca, Bayer, Bristol Myers Squibb, Johnson & Johnson, Apotex, Paladin Labs, Pharmascience, Sandoz, etc, among various others.
UK Digital Biomarkers Market Analysis
UK Digital Biomarkers Market was valued at $75.40 Mn in 2023 and is predicted to grow at a CAGR of 20.3% from 2023 to 2030, to $274.94 Mn by 2030. The key drivers of this industry include the high prevalence of chronic diseases, focus on preventative healthcare, government initiatives, and growing interest in personalized medicine. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Canada Medication Access Programs Market Analysis
The Canada Medication Access Programs Market was valued at $439.2 Mn in 2023 and is predicted to grow at a CAGR of 14.6% from 2023 to 2030, to $1140 Mn by 2030. The key drivers of this industry include chronic disease prevalence, rising healthcare costs, and pharmaceutical support. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.
France Cancer Induced Bone Disease Therapeutics Market
France Cancer Induced Bone Disease Therapeutics Market valued at $36 Mn in 2022, projected to reach $52 Mn by 2030 with a 4.8% CAGR. The key drivers of this industry include the increasing prevalence of different cancers, unmet medical needs of the population, and supportive government initiatives. The industry is primarily dominated by players such as Amgen, Novartis, Pfizer, Roche, Eli Lilly, Johnson, and Bayer, among others.
China Congestive Heart Failure Therapeutics Market Analysis
The China Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $0.828 Bn in 2022 to $1.455 Bn by 2030, with a CAGR of 7.3% during the forecast period of 2022-2030. The market in China is driven by a confluence of various factors including a rapidly aging population, urbanization-induced lifestyle changes that increase the incidence of cardiovascular risk factors, and ongoing efforts to develop healthcare infrastructure, all of which contribute to increased demand for therapeutics. The China Congestive Heart Failure Therapeutics Market is dominated by key players from various therapeutic segments, including AstraZeneca, Bayer, Novartis, Eli Lilly, Merck, Sanofi, Jiangsu Hengrui Medicine, Shanghai Fosun Pharmaceutical, Shenzhen Chipscreen Biosciences, Guangzhou Kangchao Pharmaceutical, among others.
France Digital Biomarkers Market Analysis
France Digital Biomarkers Market was valued at $79.75 Mn in 2023 and is predicted to grow at a CAGR of 21.3% from 2023 to 2030, to $308.15 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and rising healthcare costs. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Egypt Cancer Induced Bone Diseases Therapeutics Market
Egypt Cancer Induced Bone Disease Therapeutics Market valued at $4 Mn in 2022, projected to reach $6 Mn by 2030 with a 7.3% CAGR. The key drivers of this industry include the rising incidence of cancer, expanding treatment options, and improved diagnoses. The industry is primarily dominated by players such as EVA, AstraZeneca, Merck, Eli Lilly, Pharco, Johnson & Johnson, Amgen, and Novartis among others.
Egypt Congestive Heart Failure Therapeutics Market Analysis
The Egypt Congestive Heart Failure Therapeutics Market is anticipated to experience a growth from $29 Mn in 2022 to $51 Mn by 2030, with a CAGR of 7.3% during the forecast period of 2022-2030. The primary drivers in Egypt are the increasing incidence of cardiovascular illnesses, increased consciousness, early detection made possible by technological developments in the field, and the revolutionary stage of CHF treatments with ongoing research and development. The Egypt Congestive Heart Failure Therapeutics Market encompasses various key players across different therapeutic segments, including AstraZeneca, Bayer, Boehringer Ingelheim, Bristol-Myers Squibb, Roche, Gilead Sciences, Copad Pharma, EVA Pharma, Pharco, Pharmaceuticals, Tabia Pharmaceuticals, etc, among various others.
China Biosensors Market Analysis
The China Biosensors Market was valued at $2323.2 Mn in 2023 and is predicted to grow at a CAGR of 9.5% from 2023 to 2030, to $4385.1 Mn by 2030. The key drivers of the market include increasing burden of chronic diseases, technological advancements, and growing demand for Point-of-Care (POC) testing. The prominent players of the China Biosensors Market are Abbott Laboratories, Biosensors International, Bio-Rad International, DowDuPont, and Masimo Corporation, among others.
Germany Digital Biomarkers Market Analysis
Germany Digital Biomarkers Market was valued at $106.14 Mn in 2023 and is predicted to grow at a CAGR of 20.5% from 2023 to 2030, to $391.55 Mn by 2030. The key drivers of this industry include advancements in technology, the growing prevalence of chronic diseases, and the focus on preventative care. The industry is primarily dominated by ActiGraph LLC, AliveCor Inc., Koneksa, and Altoida Inc. among others.
Saudi Arabia Medication Access Programs Market Analysis
The Saudi Arabia Medication Access Programs Market was valued at $93.3 Mn in 2023 and is predicted to grow at a CAGR of 16.1% from 2023 to 2030, to $265.3 Mn by 2030. The key drivers of this industry include increasing chronic disease burden, government initiatives, and pharmaceutical innovation. The industry is primarily dominated by players such as Gilead Sciences, Takeda Pharmaceuticals, Pfizer, and Novartis among others.